Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre.

Background: We sought to evaluate the adequacy of follow-up of thyroid cancer patients at a Canadian centre. Methods: We mailed a survey to the family physicians of thyroid cancer patients and analyzed the findings relative to follow-up guidelines published by the American Thyroid Association (ATA). Statistical significance between early and late follow-up patterns was analyzed using the chi(2) test. Results: Our survey response rate was 56.2% (91 of 162). The time from operation ranged from 1.24-7.13 (mean 3.96) years, and 87.9% of patients had undergone a physical exam within the previous year. Only 37.4% and 14% of patients had a serum thyroglobulin measurement within 6 and between 6 and 12 months before the survey, respectively. Thyroid simulating hormone (TSH) levels were measured within the prior 6 months in 67% of patients and between 6 and 12 months in 13.2%. The TSH levels were suppressed (< 0.1 mu IU/L) in 24.2% of patients, 0.1-2 mu IU/L in 44% and greater than 2 mu IU/L in 17.6%. Ultrasonography was the most common imaging test performed. Conclusion: There is significant variation in the follow-up patterns of patients with thyroid cancer, and there is considerable deviation from current ATA guidelines.